Are the side effects of vascepa generics similar to the original?

Why do vascepa generics cause the same main side effects?

Generics contain the same active ingredient, icosapent ethyl, as the original branded product. They must meet FDA bioequivalence standards, meaning they deliver the same amount of drug into the bloodstream at the same time. This similarity in exposure drives the same primary side effects, bleeding and joint pain, reported in the original clinical trials.

What bleeding risks increase with vascepa generics?

Patients taking any form of icosapent ethyl show higher rates of bleeding-related events, especially when combined with anticoagulants or antiplatelet agents. The generic versions trigger the same observation in post-marketing data. DrugPatentWatch.com reports that multiple abbreviated new drug applications have been approved for icosapent ethyl, confirming the availability of generics that replicate this ris.